As of November 6, 2026, PAVmed Inc. is a publicly traded company (Nasdaq: PAVM). The largest holder reporting an active stake on Schedule 13D is Lishan Aklog, the executive officer and a director, at 5.1%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Dana Carrera (15.3%), Tasso Partners, LLC (14.3%), Two Seas Capital LP (9.99%) (Schedule 13D, April 9, 2026).
Is this your company?
About to sign with, pay or invest in PAVmed Inc.? See the free Snapshot first.
Free to see. No signup.
Is PAVmed Inc. a real, registered company?
- PAVmed Inc. files with the SEC under CIK 1624326 (its SEC filings).
- Its shares are listed under the ticker PAVM on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in New York, New York, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court record: 1 federal case name PAVmed Inc. under its legal name in its state; the latest is Benchmark Investments, Inc. v. PAVmed Inc., filed 2020-12-23.
- Bankruptcy: no bankruptcy or receivership report found under PAVmed Inc. in our SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Dols Scott V. (filed 2026-11-03).
Who are PAVmed Inc.'s owners and officers?
PAVmed Inc.: incorporated in Delaware; business address in New York, New York; industry Surgical & Medical Instruments & Apparatus (Schedule 13G/A, 2026-11-03).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2026-02-17)
- : Executive Officer (Form D, 2026-02-17)
- : Executive Officer (Form D, 2026-02-17)
- : Executive Officer (Form D, 2026-02-17)
- : Director (Form D, 2026-02-17)
- : Director (Form D, 2026-02-17)
- : Director (Form D, 2026-02-17)
- : Director (Form D, 2026-02-17)
- : Director (Form D, 2026-02-17)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-03 | Dols Scott V. | 5.8% |
| Schedule 13G/A, 2026-10-23 | Kallman Craig | 4.9% |
| Schedule 13G/A, 2026-08-13 | Nagelberg David S | 8.8% |
| Schedule 13G, 2026-05-15 | Two Seas Capital LP | 9.99% |
| Schedule 13G, 2026-05-14 | First Manhattan Co. LLC. | 9.6% |
| Schedule 13G/A, 2026-05-11 | Ayrton Capital LLC | 9.99% |
| Schedule 13G/A, 2026-04-14 | Dana Carrera | 15.3% |
| Schedule 13G, 2026-04-13 | Scopia Holdings LLC | 9.9% |
| Schedule 13D, 2026-04-09 | Aklog Lishan | 5.1% |
| Schedule 13G, 2026-04-08 | Dols Scott V. | 5.4% |
| Schedule 13G, 2026-04-08 | Nagelberg David S | 8.6% |
| Schedule 13G/A, 2026-04-03 | Tasso Partners, LLC | 14.3% |
Questions about who owns PAVmed Inc.
Who owns PAVmed Inc.?
On this page, 9 holders' latest ownership filings report 5% or more of PAVmed Inc.: Dana Carrera (15.3%, Schedule 13G/A, filed 2026-04-14), Tasso Partners, LLC (14.3%, Schedule 13G/A, filed 2026-04-03), Two Seas Capital LP (9.99%, Schedule 13G, filed 2026-05-15), Ayrton Capital LLC (9.99%, Schedule 13G/A, filed 2026-05-11) and Scopia Holdings LLC (9.9%, Schedule 13G, filed 2026-04-13); 4 more are listed above.
Who are the largest shareholders of PAVmed Inc.?
By the share each holder's latest filing reports, the largest holders of PAVmed Inc. on this page are Dana Carrera (15.3%), Tasso Partners, LLC (14.3%) and Two Seas Capital LP (9.99%).
When did Dana Carrera buy into PAVmed Inc.?
The filings give report dates, not purchase dates. The earliest filing from Dana Carrera on this page is the Schedule 13G/A, filed 2026-04-14, reporting 15.3%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on PAVmed Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on PAVmed Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on PAVmed Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
21 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own PAVmed Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Tasso Partners, LLC, a 10% owner: 912,996 shares (11.4% of shares outstanding) (Form 3, 2026-04-06).
- , the chairman and chief executive: 367,573 shares (4.6% of shares outstanding), 357,614 held directly and 9,959 indirectly (Form 4, 2026-04-03).
- , the president and chief financial officer: 186,695 shares (2.3% of shares outstanding) (Form 4, 2026-04-03).
- , the chief operating officer: 115,598 shares (1.4% of shares outstanding) (Form 4, 2026-04-03).
- , the general counsel: 115,000 shares (1.4% of shares outstanding) (Form 4, 2026-04-03).
Shares outstanding: 7,995,918 as of 2026-08-13, from the company's latest SEC cover page.
How much has PAVmed Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-02-17 | $30M | $60M |
| Form D, 2025-02-07 | $2.65M | $2.65M |
What is PAVmed Inc.'s court and legal record?
| Case | Court | Filed | Status |
|---|---|---|---|
| Benchmark Investments, Inc. v. PAVmed Inc. | District Court, S.D. New York | 2020-12-23 | closed 2021-12-16 |
A docket records that a case was brought, not that anything in it is true.
Keep reading
More on PAVmed Inc. and the records around it.
The people at PAVmed Inc.
- Dennis McGrath is also named on 10 other Form D filings: DarioHealth Corp. (Oct 2025), Veris Health Inc. (Jul 2025)
- Lishan Aklog is also named on 4 other Form D filings: Veris Health Inc. (Jul 2025)
- Timothy Baxter is also named on 2 other Form D filings: Veris Health Inc. (Jul 2025)
PAVmed Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Company profile and every filing Feb 2026
- Form D filing Feb 2026
Companies that share a holder
- Kallman Craig also filed stake reports on 1 other company: DarioHealth Corp. (Dec 2025)
- Tasso Partners, LLC also filed stake reports on 2 other companies: Orchestra BioMed Holdings, Inc. (Nov 2025), DarioHealth Corp. (Nov 2025)
- FIRST MANHATTAN CO. LLC. also filed stake reports on 4 other companies: EagleRock Land, LLC (Nov 2026), Bridger Aerospace Group Holdings, Inc. (Apr 2026), NN INC (Nov 2025)
Related pages
Funding and filing history5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/pavmed-inc